Ying-Hwa Chen

Dr. Ying-Hwa Chen


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2012 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
PHPo-Hsun Huang
Po-Hsun Huang
JCJaw-Wen Chen
Jaw-Wen Chen
CLChih-Pei Lin
Chih-Pei Lin
YCYing-Hwa Chen
Ying-Hwa Chen
CWChao-Hung Wang
Chao-Hung Wang
SLShing-Jong Lin
Shing-Jong Lin
Background: Far infra-red (IFR) therapy was shown to exert beneficial effects in cardiovascular system, but effects of IFR on endothelial progenitor cell (EPC) and EPC-related vasculogenesis remain unclear. We hypothesized that IFR radiation can restore blood flow recovery in ischemic hindlimb in diabetic mice by enhancement of EPCs functions and homing process. Materials and methods: Starting at 4 weeks after the onset of diabetes, unilateral hindlimb ischemia was induced in streptozotocine (STZ)-induced diabetic mice, which were divided into control and IFR therapy groups (n = 6 per group). The latter mice were placed in an IFR dry sauna at 34°C for 30 min once per day for 5 weeks. Results: Doppler perfusion imaging demonstrated that the ischemic limb/normal side blood perfusion ratio in the thermal therapy group was significantly increased beyond that in controls, and significantly greater capillary density was seen in the IFR therapy group. Flow cytometry analysis showed impaired EPCs (Sca-1+/Flk-1+) mobilization after ischemia surgery in diabetic mice with or without IFR therapy (n = 6 per group). However, as compared to those in the control group, bone marrow-derived EPCs differentiated into endothelial cells defined as GFP+/CD31+ double-positive cells were significantly increased in ischemic tissue around the vessels in diabetic mice that received IFR radiation. In in-vitro studies, cultured EPCs treated with IFR radiation markedly augmented high glucose-impaired EPC functions, inhibited high glucose-induced EPC senescence and reduced H2O2 production. Nude mice received human EPCs treated with IFR in high glucose medium showed a significant improvement in blood flow recovery in ischemic limb compared to those without IFR therapy. IFR therapy promoted blood flow recovery and new vessel formation in STZ-induced diabetic mice. Conclusions: Administration of IFR therapy promoted collateral flow recovery and new vessel formation in STZ-induced diabetic mice, and these beneficial effects may derive from enhancement of EPC functions and homing process.

2 May 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
SCSu-Chan Chen
Su-Chan Chen
YYYa-Ling Yang
Ya-Ling Yang
CWCheng-Hsueh Wu
Cheng-Hsueh Wu
SHShao-Sung Huang
Shao-Sung Huang
WCWan Leong Chan
Wan Leong Chan
HLHSIN-BANG LEU
HSIN-BANG LEU
Background: Malnutrition is associated with poor outcomes in patients with cancer, heart failure and chronic kidney disease. This study aimed to investigate the predictive value of the Controlling Nutritional Status (CONUT) score in coronary artery disease (CAD) patients. Methods: We recruited a cohort of 3118 patients with CAD undergoing percutaneous coronary intervention (PCI) from 2005 to 2015. Nutritional status was evaluated using the CONUT score, with higher scores reflecting worse nutritional status. Results: After adjustment for comorbidities and medication, an increased CONUT score was independently associated with a higher risk of acute myocardial infarction (AMI) (HR: 1.13; 95% CI: 1.03–1.24), cardiovascular (CV) death (HR: 1.18; 95% CI: 1.07–1.30), congestive heart failure (CHF) (HR: 1.11; 95% CI: 1.04–1.18), a major adverse cardiovascular event (MACE) (HR: 1.14; 95% CI: 1.07–1.22), and total CV events (HR: 1.11; 95% CI: 1.07–1.15). The subgroup analyses demonstrated that the association of the CONUT score existed independently of other established cardiovascular risk factors. In addition, CONUT significantly improved risk stratification for myocardial infarction (MI), cardiac death, CHF, MACEs and total CV events compared to conventional risk factors in CAD patients by the significant increase in the C-index (p < 0.05) and reclassification risk categories in cardiac death and MACEs. Conclusions: The CONUT score improved the risk prediction of adverse events compared to traditional risk factors in CAD patients after percutaneous coronary intervention (PCI).

1 July 2022 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
YCYing-Hwa Chen
Ying-Hwa Chen
HCHsiao-Huang Chang
Hsiao-Huang Chang
TLTan-Wei Liao
Tan-Wei Liao
HLHsin-Bang Leu
Hsin-Bang Leu
ICI-Ming Chen
I-Ming Chen
SLSu-Man Lin
Su-Man Lin

1 January 2018
Verified
Journal Article
Closed access
YCYing-Hwa Chen
Ying-Hwa Chen
SHShao-Sung Huang
Shao-Sung Huang
SLShing-Jong Lin
Shing-Jong Lin

1 November 2023 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Open access
GTGilbert H.L. Tang
Gilbert H.L. Tang
JSJulianne Spencer
Julianne Spencer
TRToby Rogers
Toby Rogers
KGKendra J Grubb
Kendra J Grubb
PGPatrick Gleason
Patrick Gleason
JSJanarthanan Sathananthan
Janarthanan Sathananthan
BACKGROUND: Coronary accessibility following redo–transcatheter aortic valve replacement (redo-TAVR) is increasingly important, particularly in younger low-risk patients. This study aimed to predict coronary accessibility after simulated Sapien-3 balloon-expandable valve implantation within an Evolut supra-annular, self-expanding valve using pre-TAVR computed tomography (CT) imaging. METHODS: A total of 219 pre-TAVR CT scans from the Evolut Low-Risk CT substudy were analyzed. Virtual Evolut and Sapien-3 valves were sized using CT-based diameters. Two initial Evolut implant depths were analyzed, 3 and 5 mm. Coronary accessibility was evaluated for 2 Sapien-3 in Evolut implant positions: Sapien-3 outflow at Evolut node 4 and Evolut node 5. RESULTS: With a 3-mm initial Evolut implant depth, suitable coronary access was predicted in 84% of patients with the Sapien-3 outflow at Evolut node 4, and in 31% of cases with the Sapien-3 outflow at Evolut node 5 ( P <0.001). Coronary accessibility improved with a 5-mm Evolut implant depth: 97% at node 4 and 65% at node 5 ( P <0.001). When comparing 3- to 5-mm Evolut implant depth, sinus sequestration was the lowest with Sapien-3 outflow at Evolut node 4 (13% versus 2%; P <0.001), and the highest at Evolut node 5 (61% versus 32%; P <0.001). CONCLUSIONS: Coronary accessibility after Sapien-3 in Evolut redo-TAVR relates to the initial Evolut implant depth, the Sapien-3 outflow position within the Evolut, and the native annular anatomy. This CT-based quantitative analysis may provide useful information to inform and refine individualized preprocedural CT planning of the initial TAVR and guide lifetime management for future coronary access after redo-TAVR. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02701283.

4 March 1997 in Circulation
Verified
Journal Article
Closed access
YCYing-Hwa Chen
Ying-Hwa Chen
Yung-Hsiang ChenYung-Hsiang Chen
Yung-Hsiang Chen
SLShing-Jong Lin
Shing-Jong Lin
CCChia-Yu Chou
Chia-Yu Chou
GMGuang-Yuan Mar
Guang-Yuan Mar
SWShih-Pu Wang
Shih-Pu Wang
Background Proliferation and matrix protein secretion of coronary smooth muscle cells (SMCs) have been suggested as one of the mechanisms responsible for the development of postangioplasty restenosis and an alternative cause of unstable angina. Phenotypic modulation of SMCs may produce a pool of cells potentially responsive to growth stimulation that can synthesize abundant extracellular matrix. This study tested the hypothesis that phenotypic modulation of SMCs occurred during the evolution of postangioplasty restenosis and unstable angina. Methods and Results The SMCs of coronary atherectomy specimens from 24 patients were identified under electron microscope. Volume fractions of synthetic organelles (VFSOs) and other features related to phenotypic modulation of SMCs were measured. The results showed that the VFSO in SMCs from 5 patients with unstable angina (group 2) resembled those from 9 patients with postangioplasty restenosis (group 3; 0.42±0.13 versus 0.36±0.10; P =NS), and both were significantly higher than those from 6 patients with stable angina (group 1; 0.21±0.11). Four patients with restenosis lesions who underwent angioplasty >6 months ago (group 4) also had a low VFSO in SMCs (0.19±0.05). This value was significantly less than those in groups 2 and 3 ( P <.05) but similar to that in group 1. Conclusions The coronary lesions from patients with unstable angina resembled those from patients with postangioplasty restenosis in terms of the phenotypic modulation and VFSO in SMCs. Our findings therefore suggest that after phenotypic modulation, the SMCs may become responsive to growth stimulation, with an ability to massively proliferate and synthesize abundant extracellular matrix. These processes may lead to plaque expansion and eventually to the development of unstable angina and restenosis.